UNCY · NASDAQ
Unicycive Therapeutics (UNCY) Stock Price & Fundamentals
Unicycive Therapeutics (UNCY) closed at $230.35 on Oct 9, 2026, up 0.84% from the previous close of $228.43.
Share price, past year
1Y −10.93%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $230.35 |
| Sep 30, 2026 | $220.40 |
| Aug 31, 2026 | $229.70 |
| Jul 31, 2026 | $231.06 |
| Jun 30, 2026 | $233.05 |
| May 29, 2026 | $237.56 |
| Apr 30, 2026 | $246.25 |
| Mar 31, 2026 | $244.24 |
| Feb 27, 2026 | $255.96 |
| Jan 30, 2026 | $247.68 |
| Dec 31, 2025 | $241.63 |
| Nov 28, 2025 | $239.42 |
| Oct 31, 2025 | $254.01 |
Key statistics
- Market cap
- $6.42B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.25
- Revenue (TTM)
- —
- Net income (TTM)
- −$35.22M
- Shares outstanding
- 27.9M
- Dividend yield
- —
- 52-week range
- $215.91 – $260.72
Unicycive Therapeutics's market cap is $6.42B, based on a share price of $230.35 and 27.9M shares outstanding as of Jun 30, 2026.
Financials
Unicycive Therapeutics reported revenue of $675.00K for fiscal 2023, down 29.02% from fiscal 2022.
Unicycive Therapeutics reported a net loss of $26.56M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2023ended Dec 31, 2023 | $675.00K | −29.0% | −$30.54M | −4,525.0% | −$1.28 | −$18.30M |
| FY2022ended Dec 31, 2022 | $951.00K | — | −$18.06M | −1,898.8% | −$1.20 | −$15.65M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2023ended Mar 31, 2023 | $675.00K | — | — |
| Q3 FY2022ended Sep 30, 2022 | $951.00K | — | — |
Company profile
- Name
- Unicycive Therapeutics, Inc.
- Ticker
- UNCY
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 1975 W. El Camino Real, Suite 204, Mountain View, CA 94040
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001766140
Recent SEC filings
- Sep 29, 2026
- Sep 28, 2026
- Aug 12, 2026
- Aug 12, 2026
- Jul 2, 2026
- Jun 22, 2026
- Jun 5, 2026
- May 12, 2026
Frequently asked questions
What is Unicycive Therapeutics's stock price?
Unicycive Therapeutics (UNCY) closed at $230.35 on Oct 9, 2026, up 0.84% from the previous close of $228.43.
What is Unicycive Therapeutics's market cap?
Unicycive Therapeutics's market cap is $6.42B, based on a share price of $230.35 and 27.9M shares outstanding as of Jun 30, 2026.
How much revenue does Unicycive Therapeutics make?
Unicycive Therapeutics reported revenue of $675.00K for fiscal 2023, down 29.02% from fiscal 2022.
Does Unicycive Therapeutics pay a dividend?
Unicycive Therapeutics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Unicycive Therapeutics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures